Mainz Biomed N.V.
MYNZ
$1.59
-$0.02-1.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.97M | -20.31M | -21.65M | -21.52M | -- |
| Total Depreciation and Amortization | 1.02M | 1.02M | 1.02M | 961.50K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.21M | 3.35M | 3.49M | 2.70M | -- |
| Change in Net Operating Assets | -721.60K | -334.90K | 51.80K | 591.50K | -- |
| Cash from Operations | -15.46M | -16.28M | -17.09M | -17.27M | -- |
| Capital Expenditure | 14.60K | -45.10K | -104.80K | -274.50K | -- |
| Sale of Property, Plant, and Equipment | 23.40K | 23.40K | 23.40K | 11.70K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 32.80K | 32.80K | 32.80K | 16.40K | -- |
| Other Investing Activities | -300.00K | -225.00K | -150.00K | -325.00K | -- |
| Cash from Investing | -229.40K | -214.10K | -198.80K | -571.50K | -- |
| Total Debt Issued | 1.34M | 2.83M | 4.31M | 3.64M | -- |
| Total Debt Repaid | -1.40M | -1.44M | -1.48M | -2.24M | -- |
| Issuance of Common Stock | 16.78M | 15.27M | 13.76M | 11.64M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.72M | 16.66M | 16.60M | 13.04M | -- |
| Foreign Exchange rate Adjustments | -99.80K | -122.90K | -146.00K | -910.80K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 933.40K | 49.10K | -835.20K | -5.71M | -- |